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ABSTRACT
Introduction Sexual and Reproductive Health and
Rights (SRHR) of young people continue to present a high
burden and remain underinvested. This is more so in low
and middle-income countries (LMICs), where empirical
evidence reveals disruption of SRHR maintenance, need
for enhancement of programmes, resources and services
during pandemics. Despite the importance of the subject,
there is no published review yet combining recent disease
outbreaks such as (H1N1/09, Zika, Ebola and SARS-COV-2)
to assess their impact on adolescents and youth SRHR in
LMICs.
Methods and analysis We will adopt a four-step search
to reach the maximum possible number of studies. In the
first step, we will carry out a limitedpreliminary search
in databases for getting relevant keywords (appendix
1). Second, we will search in four databases: Pubmed,
Cochrane Library, Embase and PsycINFO. The search
would begin from the inception of the first major outbreak
in 2009 (H1N1/09) up to the date of publication of the
protocol in early 2022. We will search databases using
related keywords, screen title & abstract and review full
texts of the selected titles to arrive at the list of eligible
studies. In the third stage, we will check their eligibility
to the included article’s reference list. In the fourth stage,
we will check the citations of included papers in phase 2
to complete our study selection. We will include all types
of original studies and without any language restriction in
our final synthesis. Our review results will be charted for
each pandemic separately and include details pertaining
to authors, year, country, region of the study, study design,
participants (disaggregated by age and gender), purpose
and report associated SRHR outcomes. The review will
adhere to the Preferred Reporting Items for Systematic
reviews and Meta-Analyses extension for Scoping Reviews
guideline (PRISMA-ScR).
Patient and public involvement Patients or public were
not involved in this study.
Ethics and dissemination Ethical assessment is not
required for this study. The results of the study will be

Strengths and limitations of this study
► Our systematic scoping review protocol minimises

the possibility of duplications and engages a stringent peer-review process to arrive at meaningful
search outcomes around Sexual and Reproductive
Health and Rights (SRHR) impacts.
► Our strategy will include four stepped approach of
searching and sifting through studies, maximising
our effort to reach all eligible studies.
► Using International Conference on Population and
Development as our guiding framework to elicit key
outcomes, we will study adolescent SRHR rigorously
and report these outcomes keeping our framework
guidelines in mind .
► There could be other localised and globally impacting diseases outbreaks to consider other than what
we focused on that merit further scrutiny.

presented in peer-reviewed publications and conferences
on adolescent SRHR.

INTRODUCTION
The beginning of sexual maturation differs
based on sex, country, culture and religious
context.1 We know that adolescents are
accessing services earlier, but the use of these
services tends to be inconsistent.2 The risk of
neglecting the adolescent sexual and reproductive health could impose a life-
lasting
impact on them. For women, adolescent pregnancy and motherhood may be mentally and
physically challenging.3 4 It may also impede
further academic and educational achievements and economic potential.5 There is a
high risk of sexually transmitted infections,
including HIV, reproductive coercion and
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RESEARCH QUESTION
What is the existing evidence regarding the impact of the
Zika virus, H1N1/09, Ebola and SARS- COV-2outbreaks
on adolescents and youth SRHR in LMICs?
Value of the proposed review
Adolescents and young people have Sexual and Reproductive Health and Rights (SRHR) needs that become
neglected and more complex during the disasters and
outbreaks.12 Besides this, we have to underscore that their
life experience is limited, and their decision-making abilities are still evolving. Consequently, their coping mechanisms and judgement capabilities to navigate complex
circumstances triggered by these extraordinary disease
outbreaks are also limited. Despite this developmental
challenge, these crises offer a belated opportunity for
governments to fill the gaps in sex education and provide
access to contraceptives, safer motherhood, safer abortion and empowerment programmes to address inequities in SRHR and protect vulnerable adolescents in time.
If governments do not take such opportunities, future
outbreaks can further compound the public health
burden, including exacerbation of mental health issues,
gender inequalities and social injustices in society. We
know that these social determinants of adolescent health
are tied together, and this review will help understand the
existing evidence and gaps. We have prioritised studying
four significant outbreaks since 2000: swine influenza
virus (H1N1/09), Ebola virus, Zika virus and SARS-CoV-2
and their impacts on the SRHR of young and adolescents
in low and middle-income countries (LMICs).
Influenza (H1N1/09)
On the first July 2009, the WHO acknowledged that the
influenza outbreak had become pandemic and called it
the Pandemic H1N1/09 virus, popularly known as “swine
influenza”. Pregnant women were considered a high-risk
group for H1/N1, as there was a higher rate of spontaneous abortion, preterm birth, low birth weight, fetal
disease as well as increased hospitalisation and maternal
2

death.13–15 In a study at the outset of the pandemic in
Australia and New Zealand, 9% of patients admitted to
the intensive care units were pregnant, a high proportion,
given that 1% of the Australasian population were pregnant.16 A global pooled analysis revealed that pregnant
women had a 3.5–25.3-fold higher risk of hospitalisation
compared with non-
pregnant women of childbearing
age.17 Due to the high mortality and morbidity rate in
for pregnant women, vaccination of pregnant women
was prioritised. However, studies show that poor vaccine
uptake in pregnant women possibly a result of concerns
regarding adverse effects.18 19 Despite multiple studies
showing that influenza vaccines are safe and have no
significant threat to pregnancy, including spontaneous
abortion, stillbirth and congenital malformations.20–22
Zika virus
In March 2015, a group of patients were admitted in
Brazil with rash, fatigue and arthralgia, caused by the Zika
Virus. In October, that year, a few reports showed that
the mother–newborn transmission of the virus23 might
lead to fetal loss, preterm delivery and microcephalic
(small head) babies, cumulatively known as congenital
Zika syndrome.24 Case reports showed high semen viral
load, 10 000 times higher in semen than in blood in one
case.25 26 The transmission of the virus in humans is via
sexual contact, blood transfusion and organ transplantation.27–29 Combining the sexual transmission of the virus
between partners and vertical transmission to the fetus,
the WHO recommendations were adoption of safer sex
practices, abstinence during pregnancy and emergency
contraception.23 To date, a total of 86 countries have
reported evidence of Zika infection.30
In mid-January 2016, the health ministers of multiple
Latin American countries recommended postponing
pregnancy for at least 6–24 months. This seemed too
idealistic and unrealistic, as more than half of the region’s
pregnancies have been unintended.31 In addition, inadequate sex education, difficulty accessing contraception, high rape prevalence and local cultural constraints
resulted in many women not adopting proper advice.32
Latin American countries have a relatively wide range of
restrictive laws in SRHR. In El-Salvador, a self-induced
abortion may lead to a penalty as high as 40 years of
incarceration.33 On the other hand, in response to the
Zika virus, the Columbian Ministry of Health declared
that women have the right to have self-induced miscarriages. Nevertheless, due to poor education and scarcity
of information, women are not well informed about the
risk and their abortion rights.32 This was reflected by the
fact that the rate of contraception usage did not change
in Columbia during the outbreak in 2015–2016.34
Ebola virus
Ebola haemorrhagic fever is one of the fatal outbreaks
within history. By the end of 2016, an estimated 11 310
deaths resulted from 28 618 definite cases, a staggering
40% mortality.35 The transmission route is through
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violence in both sexes, with severe impacts seen especially for girls.6 In 2016, it was found that 15–19-year-old
adolescents in developing countries had over 21 million
pregnancies, and approximately than half of them (12
million) resulted in child delivery.7 The number of unintended pregnancies in girls between 15 and 19 years were
around 10 million, and about 55% of these unintended
pregnancies resulted in abortion.8 9 Nearly, 70% of the
total abortion attempts at the ages of 15–19 lead to unsafe
abortions that can trigger catastrophic health effects.9 In
the Global Burden of Disease 2015 report, the maternal
mortality rate was highest in 10–14-
year-
old girls. The
ratio was as high as 278/100 000 (95% UI 229 to 339).10
Additionally, pregnancy and delivery-
related complications cause more mortality in 15–19-year-old girls than
other age groups.11
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SARS-CoV-2
In late 2019, multiple patients were diagnosed with a
pneumonia-causing virus. Numerous subsequent studies
showed a beta-
coronidae family virus named ‘SARS-
CoV-
2’ by WHO to be the causative agent. In March
2020, the WHO declared SARS-CoV-2 a pandemic and
called the disease ‘coronavirus disease of 2019’, or simply
‘COVID-19’. Currently, there is no substantial evidence
that the virus is transmitted sexually or through breast
feeding. The possibility of vertical transmission is controversial. However, a recently published systematic review
and meta-
analysis suggest that a minority of pregnant
women can transmit the virus to newborns.62
As the COVID-19 escalated, many countries adopted
lockdown measures to mitigate the virus spread. The
pandemic disrupted the supply chain of key contraceptive commodities.63 In practice, most governments categorised sexual and reproductive health (SRH) services as
non-essential and forced them to close. In late April 2020,
United Nations Population Fund predicted an estimated
7 million unintended pregnancies would occur,64 as a
result of lack of access to SRH services like contraception
and safe abortion care and time-sensitive potentially lifesaving services.65
COVID-19 has forced nearly 1.4 billion children and
youths out of school/university, including 743 million
girls globally.66 This has raised concerns around long-term
impact on their lives. As in addition to increasing poverty
levels, they might also experience increased sexual and
GBV, furthering the need not only for remediation and
support services but also access to emergency contraception and other reproductive health services.67 COVID-19
has impacted health systems and services severely globally. It has also led to closure of educational institutions’,
public places for recreation and leisure, and has impacted
movement.68 The protracted closures across the world
have increased concerns around mental well-being and
the availability/accessibility of critical SRH services for
adolescents in LMICs.69
The Guttmacher institute predicted that with a hypothetical 1 year 10% decline in the use of short and long-acting
contraceptives in LMICs during the COVID-19 pandemic,
49 million women would lose their access to contraception of their choice. They estimated that around 15
million unintended pregnancies might occur, leading to
an additional 1.7 million deliveries, 2.6 million newborns
with significant complications, 168 000 newborn deaths
and 28 000 maternal deaths. The second hypothesis was
that with a yearly 10% shift of safe abortion to unsafe
abortion, an additional 3.3 unsafe abortions might occur
in LMICs, and 1000 maternal deaths are expected.63 We
know that the impact is possibly more than a 10% decline
in such services, as frontline partners have predicted a slip
could be up to 80%.70 In India, by March 2020, compared
with December 2019, a 36% decrease in injectable contraceptives use and a 21% reduction in Intrauterine devise
(IUD) insertion were reported. Simultaneously, the
distribution of the condoms and oral contraceptive pills
3
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contact with infected patient’s blood or secretions and
direct contact (mucus membrane and injured cutaneous
tissue). Even after recovery, the virus may exist in the
semen of cases for up to 7 weeks later.36 Burial ceremonies that require direct contact with the dead bodies
contribute to Ebola transmission.37 The latter endanger
women as they have significant roles in the ceremony.
Pregnant women can also transmit the virus to their
babies either in-utero or through breastmilk.38–40
In the past century, multiple outbreaks of the Ebola
virus occurred; the first one was in Zaire (currently
known as the Democratic Republic of the Congo) and
Sudan in 1976. The second outbreak occurred in Sudan
around 1979. The third epidemic was in Gabon,1996.
In this century, Northern Uganda faced the fourth
epidemic in the fall of 2000. The 2014–2016 Ebola virus
epidemic was the largest outbreak of the Ebola, considered a pandemic41 42. The outset was from Guinea and
then moved to other countries such as Liberia and Sierra
Leone. The current outbreak (2018- now) in the eastern
Democratic Republic of Congo is the last reported
outbreak.43
WHO Advisory Group on the Ebola Virus Disease
Response recommended that the male who survived the
Ebola virus disease practice hygiene and safer sex until
1 year from symptom beginning or after two negative
semen specimens for the Ebola virus. In some patients
after recovery, Ebola virus can persist in several tissues,
such as testicles, the eye and the central nervous system.44
In women who have contracted the disease during pregnancy, the virus remains in the placenta, amniotic fluid
and fetus. In those women who have been infected during
breastfeeding, the virus could persist in breast milk.38 45–50
Ebola revealed many problems in adolescence SRHR in
Africa.51 It is well established that in humanitarian crises
and disasters, women and girls are more vulnerable to
gender-based violence (GBV).52 53 Multiple studies showed
that in Sierra Leone, during the Ebola outbreak, the rate
of adolescent pregnancy, rape, sexual and gender-based
violation increased.51 54 55 United Nations Department of
Political Affairs estimates that the teenage pregnancy rate
increased by 65% during the outbreak.56 More girls were
forced into prostitution/transactional sex due to family
members’ loss and financial insecurity.57 This makes the
girls two times victims, as pregnant girls are forbidden
to attend school in Libera and Sierra Leone.58 In Sierra
Leone, Ebola increased the fear of clinic attendance and
impacted newborn and maternal care by disrupting the
health services. This led to 549 maternal deaths, 2161
neonatal deaths and 883 still births in the year 2014–
2015.59 The studies showed that even after pandemics in
Liberia and Sierra Leone, the level of contraceptive care
and family planning had returned or exceeded the baseline level after 6 months60 to 24 months.61 After 6 months
of the outbreak in Guinea, the number of family planning sessions and prenatal care visits did not reverse to
the prior level, harshly influencing the already insufficient care level.60
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PICOS framework for systematic reviews
Population
Intervention/exposure

Adolescents and youths living in
LMICs ages 10–24 years
SARS-CoV-2, Zika, H1N1 and
Ebola-related disruptions

Comparative/control
intervention

n/a

Outcome

SRHR (sexual well-being, sexual
health and illness outcomes,
reproductive health and illnesses,
sexual and reproductive health
services outcomes)
All types of original articles

Study designs

PICOS stands for Population, Intervention or exposure,
Comparative or Control Intervention, Outcome and Study Design.
LMICs, low and middle-income countries; SRHR, Sexual and
Reproductive Health and Rights.

dipped 23% and 15%, respectively. The COVID-19 has
interrupted the prevention programmes and impacted
the household economic status and is expected to result
to 13 million child marriages and two million female
genital mutilations in the next decade.54 The health
record analysis showed a 68% reduction in HPV vaccination from February to early April 2020.71
We aim to conduct a scoping review to map the range,
extent and nature of effects of H1N1, Ebola virus, Zika
virus and SARS-CoV-2 on SRHR among adolescents and
youth in LMICs. Our goal is to identify current evidence
in the literature, identify research gaps and suggest future
research. The details pertaining to population, exposure
and outcomes are provided in table 1. Our data charting
table is also available in (online supplemental table A-1).

OBJECTIVE
What is the existing evidence regarding the impact of
theH1N1/09, Ebola, Zika virus and SARS-CoV-2 outbreaks
on adolescents and youth SRHR in LMICs?

METHOD
We will use Preferred Reporting Items for Systematic
reviews and Meta-Analyses extension for Scoping Reviews
Statement, showed in online supplemental figure 1, to
report the findings of our review.72
Patient and public involvement
Patients or public were not involved in this study.
Eligibility criteria study designs
sectional studies, case–control,
We will include cross-
cohort studies, clinical trials and qualitative studies.
4

Participants/population
As per WHO definition of young people, we are considering ages 10–24 to denote adolescents and youth.
Exposure/intervention
This study is designed to assess the impact of the H1N1/0,
Ebola virus and Zika virus, and SARS-CoV-2 on adolescents and youth SRHR in LMICs. The review will include
work published after 2009.
Control
There is no control group in this review.

OUTCOME
We will focus on the SRHR of adolescents and youth in
LMICs. SRHR would consist of SRH access and services
being and illness
outcomes, sexual health and well-
outcomes, reproductive health, reproductive health,
rights and illnesses, SRH access and services outcomes.
Our proposed outcome indicators inspired by the
International Conference on Population and Development Programme of Action and sustainable development
goal 203073 74 are summarised in table 2.
Timing
The first significant outbreak of the third millennium was
the H1N1/09 (swine influenza) in 2009; hence, all the
papers published from 2009 until 2021 will be included.
Setting
Our study will focus on LMICs. LMICs were defined
according to the 2020–2021 World Bank classification.75
Language
Our review compiles articles with no language restriction.
We will use Google Translate for the primary translation
of abstracts of non-English articles. In case the abstract
of the article fits the scope of this review, we will request
the experts in SRHR familiar with that specific language,
to evaluate the paper based on the inclusion/exclusion
criteria and extract the data. Alternatively, we will request
official language translation centres to make the English
version of the article for our evaluation.

EXCLUSION CRITERIA
all non-original papers
Those irrelevant to the SRHR
Studies that do not include adolescents and youth
(10–24 years old)
► Studies from countries not categorised as LMICs
► Those not relevant to Zika virus, Ebola virus, H1N1/09
and SARS-COV-2 outbreaks.
► Full text is not available for evaluation
► If the population comprises of other ages besides
10–24, we will include it if data are disaggregated by
age group or subgroup analysis on age 10–24. If they
►
►
►
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Table 1 PICOS format in this review

Open access

Category of outcome(s)

Sub-category of interest

A) Contraception

► The proportion of adolescent and youth have access to contraceptive

B) SRH service availability and access

► The proportion of facilities providing SRHR services for adolescents

agent or procedures during the outbreaks
and youth during the outbreaks

► The proportion of health facilities providing postabortion care and

postpartum care for adolescent and youth and also services for those
who have contracted HIV in our target group during the outbreaks

C) Knowledge about SRHR

► The proportion of adolescent and youth have basic knowledge on

D) Adolescent fertility

► The adolescents and youth’s birth rate during the outbreaks
► The proportion of pregnancies related to those 24 years old and below

SRHR during the pandemics

during the outbreaks

E) Quality of care, including respect for rights

► The proportion of females are knowledgeable about side effects of

their contraceptive method of choice and how to deal with adverse
effects and also are familiar with other methods of contraception
during the outbreaks
► The universal access to contraceptives and SRHR information during
outbreaks in national policy actions during the outbreaks
► An indicator reflective of respectful care and human rights in the
provision of SRH information and services during the outbreaks
F) Prevention of sexually transmitted infections

► The rate of HPV vaccination during the epidemics

G) Abortions:

► Number of unsafe abortions during outbreaks
► Number of facilities provide safe abortions services; or if it’s illegal,

the number of facilities providing the services when unsafe abortions
become complicated during the outbreaks

H) Comprehensive sexuality education

► The proportion of school/facilities providing comprehensive sexual

I) Gender equality in SRHR

► Whether adolescents and youth’s sexual autonomy within marriage is

education during the outbreaks

respected during the outbreaks

SRHR, Sexual and Reproductive Health and Rights.

►

have included vivid results about this age group, we
will consist of their study.
Animal studies

INFORMATION SOURCES
We will look at four databases in our review: Pubmed,
Cochrane Library, Embase and PsycINFO.
Search
Online supplemental table A-
2 shows our proposed
search strategy in Pubmed. Online supplemental tables
A-3 to A-5 is our search strategy for each of the other
target databases (Cochrane Library, Embase, PsycINFO).
Selection of sources of evidence
A four-
step search strategy is being followed in this
study. First, the authors have done a preliminary (and
limited) search in several databases (Pubmed and Google
Scholar) on this topic. We assessed the keywords, abstract
Akbarialiabad H, et al. BMJ Open 2022;12:e051216. doi:10.1136/bmjopen-2021-051216

and several full texts to reach our study’s final keywords.
We discussed our search strategy multiple times until all
authors reached a consensus reflected in online supplemental table 3-
8. Following the duplication removal,
title/abstract and full-
text screening of studies using
RAYYAN,76 we will choose our relevant evidence considering the inclusion/exclusion criteria.
In the third step, we will check the articles’ reference
lists to find more relevant studies. Finally, we will look for
studies that have cited or included studies and check them
for their eligibility. Any discrepancy would be addressed
via discussion until consensus is reached in each stage.
Two authors worked separately in all searching and
extraction stages, and discrepancies would be resolved
through discussion.
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Table 2 The outcomes in our review

Open access
peer-reviewed. Any opinions or recommendations discussed are solely those
of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and
responsibility arising from any reliance placed on the content. Where the content
includes any translated material, BMJ does not warrant the accuracy and reliability
of the translations (including but not limited to local regulations, clinical guidelines,
terminology, drug names and drug dosages), and is not responsible for any error
and/or omissions arising from translation and adaptation or otherwise.

Data items
Following the selected papers’ primary selection and
inclusion and extracting the results, the tabulation phase
begins. We will categorise the extracted data based on the
items mentioned before. We will extract the following
data: authors, year, country and continent (region of the
study), study design, participants (differentiated by age
and gender), purpose and main findings. Any disagreements in the process of data extraction will be resolved
through discussion until consensus. We will also indicate
the country’s income level where studies are being done
(low, lower-middle and higher-middle income).

Open access This is an open access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work non-commercially,
and license their derivative works on different terms, provided the original work is
properly cited, appropriate credit is given, any changes made indicated, and the use
is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Critical appraisal of individual sources of evidence and
synthesis of result
Based on the nature of scoping review, we will neither
synthesise the findings/results, nor critically appraise the
papers, which is more applicable by performing a systematic review.77 However, publications and the mentioned
data would be summarised and categorised.
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